Wendy Brooks, a patient with extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, sat down ...

The FDA has granted breakthrough therapy designation to INCA033989 for some patients with essential thrombocythemia.

Time and resilience have transformed the author's cancer experience into a fading memory, allowing life to return to normal.

The U.S. Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with ...

Stage 4 metastatic breast cancer presents significant emotional and psychological challenges, requiring patients to adapt ...

Recurrent or metastatic nasopharyngeal carcinoma is an aggressive disease, and long-term survival with chemotherapy alone is ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

The author cherishes family time during Thanksgiving and Christmas, despite undergoing cancer treatment. Chemotherapy and radiation therapy were completed during the 2018 holiday season, with minimal ...

Light the Night walk fosters community and remembrance for those affected by blood cancer, with symbolic lanterns for support ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

Real and sham acupuncture were both linked to clinically meaningful and lasting improvements in perceived cognitive ...

The U.S. Food and Drug Administration (FDA) has approved niraparib (Zejula) plus Akeega (abiraterone acetate) and prednisone ...